Table 2.
Antimicrobial agents | Dosage | |
In stable, non-critical patients | ||
With no ESBL-associated risk factors | Amoxicillin/clavulanate | 2.2 g every 6 h (2-h infusion time) |
Ciprofloxacin | 400 mg every 8 h (30-min infusion time) | |
+ | ||
Metronidazole | 500 mg every 6 h (1-h infusion time) | |
With ESBL-associated risk factors | Tigecycline | 100 mg LD then 50 mg every 12 h (2-h infusion time) |
In critically ill patients | ||
With no ESBL-associated risk factors | Piperacillin/tazobactam | 9 g LD then 18 g per day via continuous infusion or 4.5 g every 6 h (4-h infusion time) |
With ESBL-associated risk factors | Piperacillin | 8 g LD then 16 g/d via continuous infusion or 4 every 6 h (4-h infusion time) |
+ | ||
Tigecycline | 100 mg LD then 50 mg every 12 h (2-h infusion time) | |
+/- | ||
Fluconazole | 600 mg LD then 400 mg every 24 h (2-h infusion time) |
ESBL: Extended-spectrum β-lactamase; LD: Loading dose.